Intercept to Report 2016 Full Year Financial Results on February 23 and Present at Upcoming Conferences

Friday, February 17, 2017 12:05 PM UTC

NEW YORK, Feb. 17, 2017 -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that it will report its fourth quarter and full year 2016 financial results prior to the NASDAQ market open on Thursday, February 23, 2017. Intercept management will conduct a conference call and audio webcast on Thursday, February 23, 2017 at 8:30 a.m. Eastern Time to discuss these results.

Intercept management will also be presenting at the following investor conferences:

2017 RBC Capital Markets Global Healthcare Conference on February 23, 2017 at 11:30 a.m. Eastern Time
37^th Annual Cowen Health Care Conference on March 6, 2017 at 4:40 p.m. Eastern Time

Webcast information for these events will be available on the Investors page of Intercept's website at http://ir.interceptpharma.com. Archived webcasts will be available on Intercept's website for approximately two weeks.

About Intercept
Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC), nonalcoholic steatohepatitis (NASH), primary sclerosing cholangitis (PSC) and biliary atresia. Founded in 2002 in New York, Intercept now has operations in the United States, Europe and Canada.

CONTACT: For more information about

Intercept Pharmaceuticals, please contact:
       

Intercept Pharmaceuticals:

Mark Vignola

+1-646-747-1000

[email protected]

     
Media inquiries: [email protected]
     
Investor inquiries: [email protected]

Editor's Picks

Breathing through your nose when you exercise may make your runs easier

Entrepreneurs are facing a mental health crisis — here's how to help them

Are fish oil supplements as healthy as we think? And is eating fish better?

Will AI kill our creativity? It could – if we don’t start to value and protect the traits that make us human

Does AI have a right to free speech? Only if it supports our right to free thought

How can I lower my cholesterol? Do supplements work? How about psyllium or probiotics?

Why we need to set limits on sperm donation

Aging with a healthy brain: How lifestyle changes could help prevent up to 40% of dementia cases

Seven techniques to avoid weight regain, approved by experts

Intercept to Report 2016 Full Year Financial Results on February 23 and Present at Upcoming Conferences

Editor's Picks

Welcome to EconoTimes